Topics:

Diabetes

Type 2 Diabetes and Medication Adherence: Where is the Disconnect?

Incretin drugs, which offer ease of use, very little hypoglycemia, and no weight gain (or even weight loss) seem to be an ideal therapy. But 80% to 90% of patients don’t stay on them. Why not?

Diabetes

Obstructive sleep apnea tracks with glycemic health, both for people who have diabetes and for others who don't.

Treatment of patients with diabetes can be difficult, and specific concerns arise in the older population regarding the safety and efficacy of this high-alert medication.

There are 2 FDA-approved sodium-glucose contransporter-2 inhibitors available in the United States. Here, a concise review of advantages/disadvantages and considerations in patient selection.

Necrobiosis

Put yourself to the test: This week’s quiz questions you about skin disease, diabetes, sarcoidosis, atrial flutter, and pain medications.

Patients with NAFLD are at high risk for development of type 2 diabetes and those with diabetes may be at higher risk of dying from NALFD-associated chronic liver disease. Here, options for prevention and treatment.

Neuroarthropathy, mucormycosis, necrobiosis lipoidica, diabetic myonecrosis, hypertriglyceridemia, papillomatosis, perleche—these visual presentations cover a range of diabetes-related problems.

Chronic kidney disease is common in patients with diabetes and can complicate treatment, but several agents may help. Here the focus is on incretin therapies.

Pages

Subscribe to Diabetes on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.